Pros and cons of immediately sequential bilateral cataract surgery (ISBCS)  by Grzybowski, Andrzej et al.
Saudi Journal of Ophthalmology (2016) 30, 244–249Review articlePros and cons of immediately sequential bilateral cataract surgery
(ISBCS)Peer review under responsibility
of Saudi Ophthalmological Society,
King Saud University Production and hosting by Elsevier
Access this article onlin
www.saudiophthaljourn
www.sciencedirect.com
Received 19 October 2015; received in revised form 28 July 2016; accepted 20 September 2016; available online 28 September 2016.
a Department of Ophthalmology, Poznan City Hospital, Poznan´, Poland
b Chair of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland
c Queen’s Hospital London, BHR University Hospitals, United Kingdom
⇑ Corresponding author at: Jozef Strus Poznan City Hospital, Department of Ophthalmology, 3 Szwajcarska St, 361-285 Poznan´,
Fax: +48 61 8739 169.
e-mail address: ae.grzybowski@gmail.com (A. Grzybowski).Andrzej Grzybowski a,b,⇑; Weronika Wasinska-Borowiec b; Charles Claoué cAbstractImmediately sequential bilateral cataract surgery (ISBCS) is currently a ‘‘hot topic’’ in ophthalmology. There are well-documented
advantages in terms of quicker visual rehabilitation and reduced costs. The risk of bilateral simultaneous endophthalmitis and bilat-
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Simultaneous bilateral cataract surgery, now more accu-
rately referred to as immediately sequential bilateral cataract
surgery (ISBCS) - to clearly differentiate it from delayed
sequential bilateral cataract surgery [DSBCS],1 is still a con-
troversial topic in the ophthalmic world and has to come a
long way to become a routine procedure. There have been
many positive studies on this subject, and every year sur-
geons convinced of the benefits of this method join together
for discussions and lectures while also attending the meet-
ings of the European Society of Cataract & Refractive Sur-
geons (ESCRS). Still, the method has as many opponents as
supporters.The aim of this review was to clarify both advantages
and disadvantages of ISBCS and a presentation of the
necessary measures that should be taken to obtain the best
results.
Methods
This is a review study. A PubMed platform search was per-
formed, using the following keywords: bilateral cataract sur-
gery, simultaneous bilateral cataract surgery, sequential
bilateral cataract surgery, same-day cataract surgery, bilat-
eral cataract extraction, ISBCS. We found 56 articles of which
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What differentiates ISBCS from DSBCS is the timing of the
second procedure. Trying to create a definition of ISBCS we
should put the greatest emphasis on the words ‘‘immediately
sequential’’. It means that the treatment is performed on one
patient during one operating session in the operating room,
in contrast to DSBCS, where between treatments one and
the other eye occur differently with an interval, which may
be several days, weeks or months. This means that the
patient leaves the hospital after the first eye surgery and
returns for the second eye operation. What connects the
two surgical definitions is ‘‘the independent performance of
two separate procedures (autonomy)’’. Although it may seem
obvious with DSBCS, this also applies to ISBCS - both treat-
ments should be carried out with complete change of drape,
appliances, and irrigation fluids.History
One of the earliest scientific reports of simultaneous
binocular cataract in one operating session comes from
1952.2 Initially this applied to ICCE operations. Over the
years, surgical techniques were refined and supporters of
ISBCS appeared. ISBCS began to become common with
the advent of small incision Phaco, although there are some
places that do it with manual small incision cataract surgery
(MSICS) now as well.
In Poland, even though there are a few surgeons who
operate simultaneously both eyes, there are few documented
cases of such operations. In the identified publications, we
discovered that in the period from January to December
1985, 48 operations by cryoextraction were performed, and
from March to June 1999 3 treatments of ISBCS were per-
formed,3,4 all due to the health of the patients requiring sur-
gery under general anesthesia. The operation of each eye
was treated as a separate procedure, and all were run under
strict aseptic conditions. In none of these cases there were
early or late postoperative period complications observed.
In 2009, 10% of responding members of the ESCRS were
performing ISBCS.1,5 The leading country for the proportion
of ISBCS done is Finland. Routine ISBCS has been common
there since 1996, and many hospitals currently perform ISBCS
on 40% to 60% of cataract patients.1,6 Spain’s region of the
Canary Islands perform 80% of all cataract surgeries in this
way with explicit government approval, which recently con-
cluded that ‘‘ISBCS, as a surgical alternative for cataract
patients, is as safe and effective as conventional DSBCS’’.7
In the Canadian province of Ontario, ISBCS has increased
from 1.02% of total cataract surgeries in 2003/2004 to
2.36% in 2009/2010, with a 40% increase in total provincial
cataract surgical volume over the same period. Thus, there
has been a consistent increase in the performance of ISBCS
in Ontario, over the 7 years from 2003 to 2010, a pattern sim-
ilar to what is currently seen worldwide. Australia was similar
to Canada in that it practices a fee-for-service reimbursement
with simultaneous second-eye discounts of 50%. In contrast
to report on ESCRS member activities, the American Acad-
emy of Ophthalmology does not endorse simultaneous pro-
cedures due to potential serious complications, such as
endophthalmitis and poorer refractive outcomes, that are
considered to be associated with the technique.8 As such,DSBCS remains the standard of care in the United States,
and ophthalmologists face financial penalties for performing
ISBCS.9,10 In Israel and Japan, ophthalmologists receive no
reimbursement for the second simultaneous bilateral cataract
surgery. In the United Kingdom, ophthalmologists received
80% of the first-eye fee for the second eye in simultaneous
bilateral cataract surgery 11 from some insurance providers,
but more often only 40%.Qualification and precautions
A fundamental and overriding principle that should be fol-
lowed is to treat each eye surgery as individual and autono-
mous, as recommended by the International Society of
Bilateral Cataract Surgeons (www.isbcs.org). It should be
noted that there have never been any reports of bilateral
simultaneous endophthalmitis if these recommendations
are followed. This applies primarily to the strict aseptic sepa-
ration. Each eye requires an absolute change of covering,
staff’s gloves, gowns and instruments.12–16 Many authors
emphasize that the instruments should come from different
sterilization cycles and substances used during the proce-
dure, such as viscoelastics or irrigation fluid, if possible,
should be from different companies or at least different
lots.14 Thus there are hidden extra activities in practicing safe
ISBCS compared to DSBCS, and nursing tasks and responsi-
bilities are subtly increased. Some operating suites are
arranged so that an operator always do left eyes first. The left
eye can be done farther away from the preparation of the
table for the right eye than vice versa in that kind of arrange-
ment of operating room.15
Information of right and left eye intraocular lens (IOL) and
astigmatism has always to be clearly marked, so that it can
easily be seen by the surgeon and all staff. Nurses should
be trained to read and interpret biometric data, which they
read out loud as they pass the IOL from the circulating table
to the scrub nurse, confirming IOL choice.14 If any significant
surgical problem remains unresolved with the first eye, con-
sideration should be given to deferring the second surgery.17
Another requirement of successful ISBCS is to prevent the
development of infection: this is because opponents cite the
risk of bilateral simultaneous endophthalmitis as the main
reason against undertaking ISBCS. Great emphasis should
be put on prophylaxis that starts with the surgery and contin-
ues through the postoperative period. Intracameral antibiotic
prophylaxis was shown to reduce the rate of endophthalmitis,
as does a well-sealed incision, and non-complicated cataract
surgery.18
There is no doubt that metal blade incisions are not as
smooth as diamond blade incisions and leak more frequently,
setting up an environment in which microbes have access to
the anterior chamber,19 and we therefore prefer diamond
blades. Which antibiotic is right to use intracamerally is
widely discussed, but there is little doubt that intracameral
antibiotics are recommended for ISBCS.
The only RCT study and majority of retrospective case ser-
ies were based on cefuroxime use. Its limitations, however,
are well known and they include complete lack of activity
against Enterococci, Pseudomonas species and Enterobacte-
riaceae species enterococci, low activity against methicillin-
resistant S. Aureus (MRSA) and S. Epidermidis (MRSE) and
increasing resistance of CoNS. It was shown in a Swedish
246 A. Grzybowski et al.prospective epidemiological study based on 464,996 opera-
tions that Enterococci and coagulase-negative Staphylococci
(CoNS) were responsible for 57% of endophthalmitis cases.20
This was recently confirmed in a retrospective review of
692,786 surgeries.21
Moreover, it was recently suggested that that these infec-
tions occur as a result of selection after cefuroxime intracam-
eral use, when the sensitive strains are killed by the
prophylaxis, whereas the resistant strains remain and prolifer-
ate.21 The same National Cataract Registry reveals that the
practice in same day bilateral surgery in Sweden is to add
100 ug ampicillin to the 1 mg cefuroxime dose, because of
its activity against enterococci.21
Vancomycin, although potent against these organisms and
most other Gram-positive bacteria, should be used in pro-
phylaxis only in justified situations. The US Centers for Dis-
ease Control’s Hospital Infection Control Practices Advisory
Committee has recommended that ‘‘the use of vancomycin
should be discouraged’’ in situations, including ‘‘routine pro-
phylaxis other than in a patient who has a life-threatening
allergy to beta-lactam antibiotics’’. It is generally believed
that the use in prophylaxis of this potent and indispensable
antibiotic against multiresistant strains will eventfully lead to
loss of its activity. Moreover, it was shown recently that post-
operative hemorrhagic occlusive vasculitis might be associ-
ated with intracameral vancomycin use.22,23
This might be of special concern since the entity may not
be present for several weeks, by which time both eyes have
undergone cataract surgery.
Moxifloxacin has a broader spectrum of activity against
common endophthalmitis pathogens and less reported bac-
terial resistance than cefuroxime, shows dose-dependent
rather than time-dependent kinetics, antinuclear efficacy,
and a low risk for allergy and is the simplest to prepare, mak-
ing dilution errors unlikely.15,24,25 Nevertheless, category 1
data (randomized prospective trial data published in peer-
reviewed journals) exists only for cefuroxime.26
The important period of risk for infection is immediately
after surgery. When the commencement of topical antibiotics
is delayed, the risk for infection greatly increases.27 We rec-
ommend that patients’ eyes is not patched post-surgery,
but rather topical eyedrops have to be commenced immedi-
ately after the procedure in high doses.
At present, according to ESCRS 2013 guidelines, the drug
of choice in the treatment of infections caused by MRSA /
MRSE is vancomycin but it is not recommended in prophylac-
tic use. Vancomycin should be reserved only for therapeutic
applications, especially endophthalmitis after cataract sur-
gery. Currently moxifloxacin is considered by many to be
the most appropriate unpreserved antibiotic eye drop to
use in post-cataract surgery period.28
We propose the use of topical drops 6 times a day for the
first 3 days and then 5 times a day for next 3 days. The
patient should ideally be instructed to use different bottles
for each eye.29
With the advent of Femto Laser-Assisted Cataract Surgery
(FLACS) there is a special conundrum for ISBCS. It is clearly
more efficient to use the Femto laser on both eyes immedi-
ately one after the other, but then one is committed to bilat-
eral surgery, even if there is a serious surgical
complication with the first eye surgery. If only one eye has
FLACS before doing the femto incisions on the second eye,a second visit to the laser room will be required with loss of
efficiency. The exact protocol for FLACS-ISBCS is currently
in evolution (Table 1).Objections
It seems to us that the objections against ISBCS are pri-
marily based on anecdote rather than published data.30 After
a systematic literature search, there were three randomized
controlled clinical trials (RCTs) found, including a total of
1900 patients. However, even though there were only ran-
domized trials included, the level of evidence was low to
moderate. Thus, there is no strong scientific background to
advice against or in favor of ISBCS according to the authors
of one publication 31 although it is not clear what benefit they
were expecting. Furthermore, as Bjorn Johansson (personal
communication) has elegantly pointed out, how could one
do a double-masked trial of ISBCS versus DSBCS? We are
aware that there are claims that obtaining the refraction from
first eye cataract surgery allows improved outcome for sec-
ond eye surgery, but these claims have not been supported
by prospective trials. The introduction of optical biometry
which has improved the predictability of optical outcomes
for normal eyes (those requiring IOLs in the +15 to +25
range) and the guidelines of the International Society of Bilat-
eral Cataract Surgeons minimize the risk of refractive sur-
prises which should in any case be mentioned as part of
obtaining informed consent.
The most serious allegations against the ISBCS are the risk
of potential bilateral vision loss as a result of bilateral compli-
cations 32 such as endophthalmitis, TASS, CMO or even
refractive surprises. The most severe of these is endoph-
thalmitis; however, there are also theoretical risks of choroi-
dal hemorrhage, corneal decompensation, cystoid macular
edema and retinal detachment.33–35 Some authors divide late
complications into ’catastrophic’ and ’non-catastrophic’. The
first one includes fungal endophthalmitis and epithelial
ingrowth whereas non-catastrophic complications include
cystoid macular edema and corneal decompensation.36,37
One more complication that is sometimes mentioned is
toxic anterior segment syndrome (TASS), which is a sterile
inflammatory reaction that usually occurs when something
is changed in the surgical protocol—the source of balanced
salt solution, brand of gloves used, instrument cleaning
detergents or methodology.5,38 The use of prepared intra-
cameral antibiotics should help to reduce this risk by minimiz-
ing errors in mixing and diluting antibiotics in the
perioperative period.10 Similarly the guidelines of the Inter-
national Society were specifically designed to minimize this
risk which unlike endophthalmitis (which should be a random
chance event) represents a preventable system failure.
The greatest fear about ISBCS is bilateral simultaneous
endophthalmitis, despite bilateral endophthalmitis being
well described in cases of DSBCS. There have been 4 cases
of simultaneous bilateral endophthalmitis reported in the
world literature and none of the operations were done
according to the protocol published by the International
Society of Bilateral Cataract Surgeons.19,39–42 In practice, it
means that aseptic rules were broken 5,43 and when safety
rules are not respected we should not be surprised to hear
of bad outcomes.
Table 1. iSBCS general principles for excellence in ISBCS 2009.
1. Cataract or refractive lens surgery should be indicated in both eyes
2. Any concomitant relevant ocular or periocular disease should be managed
3. The complexity of the proposed ISBCS procedure should be easily within the competence of the surgeon
4. The patient should provide suitable informed consent for ISBCS, being free to choose ISBCS or DSBCS
5. The risk for Right – Left eye errors should be minimized by listing all surgical parameters (selected IOL, astigmatism, etc.) for both eyes on a board
visible to all in the operating room (OR), at the beginning of each ISBCS case. The WHO operative checklists should also be used if possiblea
6. Intraocular lens power errors are minimized by having OR personnel familiar with the calculation methods used. The original patient charts should
be available in the OR, and everybody passing the IOL to the surgical table should confirm the IOL choice. ISBCS nursing staff should be
specifically trained and experienced
7. Complete aseptic separation of the first and second eye surgeries is mandatory to minimize the risk of post-operative bilateral simultaneous
endophthalmitis (BSE)
a. Nothing in physical contact with the 1st eye surgery should be used for the 2nd
b. The separate instrument trays for the two eyes should go though complete and separate sterilization cycles with indicators
c. There should be no crossover of instruments, drugs or devices between the two trays for the two eyes at any time before or during the
surgery of either eye
d. Different OVDs, and different manufacturers or lots of surgical supplies should be used, whenever reasonable (where the device or drug type
has ever been found to be causative of endophthalmitis of toxic anterior segment syndrome) and possible (if different lots or manufacturers
are available) for the Right and Left eyes.
e. Nothing should be changed with respect to suppliers or devices used in surgery without a thorough review by the entire surgical team, to
assure the safety of proposed changes
f. Before the operation of the second eye, the surgeon and nurse shall use acceptable sterile routines of at least re-gloving after independent
preparation of the second eye’s operative field
g. Intracameral antibiotics have been shown to dramatically reduce the risk of post-operative endophthalmitis. Their use is strongly
recommended for ISBCS
8. Any complication with the first eye surgery must be resolved before proceeding. Patient safety and benefit is paramount in deciding to proceed
to the 2nd eye
9. ISBCS patients should not be patched. Post-operative topical drops are most effective immediately post-operatively and should be begun
immediately post-op, in high doses, which can be tapered after the first few days. Other ophthalmic medications (e.g. for glaucoma) should be
continued uninterrupted
10. ISBCS surgeons should routinely review their cases and the international literature to be sure that they are experiencing no more than
acceptable levels of surgical and post-operative complications. Membership in the International Society of Bilateral Cataract Surgeons (www.
iSBCS.org) is highly recommended to keep abreast of the latest ISBCS information
a Haynes et al. 59.
Table 2. Cases of bilateral endophthalmitis.
Reference Patient
(age/sex)





































Immediately sequential bilateral cataract surgery 247In the ESCRS prophylactic intracameral cephalosporin
studies, the incidence of postoperative endophthalmitis after
unilateral cataract surgery weight-averaged to 1 in 331 (0.3%)
without prophylactic intracameral antibiotics and to 1 in 1977
(0.05%) with prophylactic intracameral antibiotics (1),
whereas studies in the United States using only topical antibi-
otics reported infection rates as low as 0.028%. (1) No bilat-
eral simultaneous endophthalmitis occurred in the 95,606
ISBCS cases collected. (1) The overall rate of postoperative
endophthalmitis after ISBCS was 1 in 5759. (1) Infection rates
were significantly reduced with intracameral antibiotics to 1
in 14,352 cases.1 The Swedish national study of the country’s
endophthalmitis rates from 2005 through 2010 (464,996
surgeries) showed an infection rate of 0.029%, lower than
that of the ESCRS endophthalmitis study (0.062%).10,44 The
risk for postoperative endophthalmitis in ISBCS appears to
be at least as low as and possibly lower than published rates
for unilateral surgery, particularly when recommended pre-
cautions are taken. Intracameral antibiotics significantly
reduced the risk for postoperative endophthalmitis.1 Further-
more, critics often equate bilateral endophthalmitis with
bilateral blindness which is not credible with modern therapy
where approximately 1/3 of eyes regain near-normal vision.10
Another disadvantage quoted by opponents of ISBCS is
that there is no possibility to plan the operation of the second
eye on the basis of the results of the first operation 33 notably
with respect to the optical outcome. On the one hand, we
know that what increases risk of inaccurate biometry is as fol-
lows: high myopia or axial length >26 mm, high hyperopia or
axial length <21 mm, axial length difference between the
eyes >1 mm, or previous refractive surgery.36 On the other
hand, none of the randomized controlled clinical trials couldprovide evidence as to the prevalence of postoperative ani-
sometropia in patients undergoing ISBCS.31 Undertaking cer-
tain eligibility criteria and careful patient selection may solve
this problem. However for ‘‘normal’’ eyes, optical biometry is
so predictable that this disadvantage is more theoretical than
that of any real clinical relevance.
A further criticism of ISBCS is that to date it has only been
practiced by the so-called elite surgeons. This seems to imply
that if more ‘‘average’’ surgeons were to undertake ISBCS we
would see more problems. The implication seems to be that
there are surgeons who would not follow safety guidelines,
but we are not aware of any evidence to support this. It
Table 3. A comparison of costs of single surgery DSBCS and ISBCS.
Reference Study group Cost type DSBCS ISBCS
O’Brien et al.49 22 Patients Total hospital cost 1566,3 CAD 1059,1 CAD
Leivo et al.50 520 Patients Hospital standard care 2376 € 2144 €
Rush et al.51 42 Patients Total ambulatory surgery center costs 767 USD 856 USD
Total cost for the 3rd-party payer for both eyes 4067 USD 3123 USD
CAD - Canadian dollar.
248 A. Grzybowski et al.seems self-evident that any surgeon who wishes to undertake
ISBCS should be aware of the International Society sugges-
tions, and follow them (Table 2).Advantages
The undoubted and greatest medical advantage of ISBCS
is the faster complete visual rehabilitation of the patient.44
Single eye surgery causes a reduction in our visual system
from two receptors to one. Second eye surgery restores a
normal balanced visual system for the patient, something
that nature has validated for millions of years.14,45
The operation prevents also other significant problem
occurring after unilateral surgery - anisometropia. Some
authors consider A-scan measurements to be inaccurate to
allow ISBCS. Experience of the clinics which carried out thou-
sands of such treatments shows that after simultaneous
binocular surgery minor errors occur and they are almost
always symmetrical and do not cause problems such as ani-
sometropia.46 Even if there is a small lapse from a target
refraction, the stereoscopic vision is immediately restored.
Furthermore, ISBCS is an ideal solution for patients who
require general anesthesia, because it obviously lower the
risk of a second anesthetic with associated risks.10,47,48
A second major advantage of ISBCS is economic - there
are lower hospital costs, more efficient use of operating room
time and more efficient use of clinic.6,11,49–52 There are also
financial advantages for the patient: faster return to work,
fewer hospital visits and only one pair of new glasses
needed.27,36,53,54 Surprisingly, calculation has been carried
out that there is potentially 1.5–2 times higher risk from
death in a road traffic accident by undergoing extra visits
for unilateral sequential cataract surgery in those suitable
for ISBCS 55 (Table 3).Conclusion
With the development of surgical techniques, better
equipment, and modern medicines, ophthalmic surgeries
are faster, and have lower risk of complications and shorter
hospitalization time. With these achievements we gain the
courage to cross new boundaries, and one of them is the
adoption of ISBCS for suitable cases. With careful patient
selection 38,56,57 and strict adherence to protocol, this is a
method with minimal risk of binocular blindness.10 However,
what we need for full success is an experienced, skilled sur-
geon.58 All this adds up to the fact that the operational risk
for ISBCS is the same or even smaller than DSBCS.40 We
hope that soon it will become a standard in many clinics.Conflict of interest
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